Kelley Anne Bruni is a seasoned professional in health systems and account management, currently serving as the Director of Key Accounts at Madrigal Pharmaceuticals since November 2025. Prior experience includes a role as Regional Account Director at Indivior from December 2021 to September 2025, and previous positions as Hospital Account Manager at ZS Pharma, Inc./AstraZeneca, and Mallinckrodt/Cadence Pharmaceuticals. Kelley Anne Bruni has also held senior account management positions at Adolor and Eli Lilly and Company, as well as senior sales specialist roles at AstraZeneca. Educational qualifications include a Bachelor of Science in Marketing from Philadelphia University, completed between 1987 and 1991.
This person is not in any teams
This person is not in any offices